Cara Therapeutics

Cara Therapeutics is an emerging biotechnology company dedicated to developing novel therapies for the treatment of pain, inflammation, and itching. Cara Therapeutics possesses both near-term clinical development opportunities and a proprietary approach to developing first-in-class novel therapies.Cara Therapeutics' most advanced patented compound, CR845, is currently undergoing clinical testing for acute pain, uremic pruritus, and pruritus. This compound exhibits analgesic, anti-inflammatory, and antipruritic activities suitable for various therapeutic applications. Additionally, Cara Therapeutics aims to leverage its proprietary drug screening technology to develop a future pipeline of first-in-class molecules targeting novel analgesic and anti-inflammatory pathways.